Nasrin Hashemi-Firouzi
Overview
Explore the profile of Nasrin Hashemi-Firouzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shahidi S, Asl S, Gholamigeravand B, Afshar S, Hashemi-Firouzi N, Samzadeh-Kermani A, et al.
Iran J Basic Med Sci
. 2024 Sep;
27(10):1268-1275.
PMID: 39229584
Objectives: Mesenchymal stem cell (MSC) transplantation represents a promising approach for treating Alzheimer's disease (AD). These stem cells, however, have a short lifespan following transplantation into recipient animals. Selenium nanoparticles,...
2.
Ramezani M, Komaki A, Hashemi-Firouzi N, Mortezaee K, Faraji N, Golipoor Z
J Chem Neuroanat
. 2024 Apr;
138:102425.
PMID: 38663119
No abstract available.
3.
Afshar S, Shahidi S, Baooshi H, Hoseini M, Esmaeili M, Hashemi-Firouzi N, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2023 Feb;
396(7):1451-1460.
PMID: 36749399
Serotonin is a neurotransmitter, which is involved in memory via its receptors. The 5-HT and 5-HT receptors mainly exist in the hippocampus, which plays an important role in memory processing....
4.
Hashemi-Firouzi N, Afshar S, Asl S, Samzadeh-Kermani A, Gholamigeravand B, Amiri K, et al.
Metab Brain Dis
. 2022 Oct;
37(8):3011-3021.
PMID: 36271966
Some mineral elements exert beneficial neuroprotection, especially in the form of nanoparticles. The aim of the present study was to evaluate the effects of selenium nanoparticles (SeNPs) and polyvinyl alcohol...
5.
Komaki A, Shahidi S, Hashemi-Firouzi N, Rafat Z, Keymoradzadeh A, Golipoor Z
Front Behav Neurosci
. 2022 Mar;
16:796230.
PMID: 35309680
Introduction: Alzheimer's disease (AD) is a neurodegenerative disease that is characterized by amyloid plaque deposits, neuronal cell loss, and memory impairment. Granulocyte-colony stimulating factor (G-CSF) is a growth factor associated...
6.
Hashemi-Firouzi N, Shahidi S, Asl S
Brain Res
. 2021 Oct;
1773:147701.
PMID: 34695393
Alzheimer's disease (AD) is a neurodegenerative disease characterized by memory decline and impaired hippocampal synaptic plasticity. The serotonin 5-HT4 receptor is involved in learning and memory processes. This study explored...
7.
Alisavari N, Soleimani-Asl S, Zarei M, Hashemi-Firouzi N, Shahidi S
Avicenna J Phytomed
. 2021 Jul;
11(4):407-416.
PMID: 34290971
Objective: Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated with impaired cognitive skills and learning and memory dysfunctions. It has been suggested that pelargonidin (PG), as an antioxidant agent,...
8.
Ramezani M, Komaki A, Hashemi-Firouzi N, Mortezaee K, Faraji N, Golipoor Z
J Chem Neuroanat
. 2020 May;
108:101804.
PMID: 32470495
The therapy based on mesenchymal stem cells(MSCs) has received growing attraction for Alzheimer's disease(AD). However, a great challenge in this regard is the low survival rate of MSCs following transplantation....
9.
Shahidi S, Hashemi-Firouzi N, Afshar S, Asl S, Komaki A
Malays J Med Sci
. 2019 Aug;
26(2):40-51.
PMID: 31447607
Introduction: Intracerebroventricular administration of streptozotocin (icv-STZ) induced apoptosis changes in neurons similar to Alzheimer's disease. The serotonergic system via its receptor involved in survival of neurons. The present study examined...
10.
Nasiri E, Alizadeh A, Roushandeh A, Gazor R, Hashemi-Firouzi N, Golipoor Z
Metab Brain Dis
. 2019 May;
34(4):1131-1143.
PMID: 31129766
Currently, mesenchymal stem cells (MSCs) based therapy has extensive attraction for Alzheimer's disease (AD). However, low survival rate of MSCs after transplantation is a huge challenging. The current study aimed...